FDA Appropriations In Senate: Money For Generics; Worry About Tobacco
Executive Summary
Senate appropriators would like to see FDA spend $93 million in fiscal year 2010 on its generic drugs program
You may also be interested in...
FDA Biosimilars Program Gets Seed Money In Administration's FY '11 Budget
FDA plans to spend $5.7 million in fiscal 2011 to develop drug review standards and make other preparations for an approval pathway for follow-on biologics
FDA Biosimilars Program Gets Seed Money In Administration's FY '11 Budget
FDA plans to spend $5.7 million in fiscal 2011 to develop drug review standards and make other preparations for an approval pathway for follow-on biologics
FDA Biosimilars Program Gets Seed Money In Administration's FY '11 Budget
Agency again requests generic user fee program, seeking to add $38 million in industry funds to $88.5 million in federal money for reviewing generics.